Journal Article Ahead of print
PubMed: 42663081 DOI: 10.1111/dme.70471
In response to comment on improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies.
Diabet Med
Authors: Rebecca C Wyatt, Cristina Brigatti, Sian L Grace, Claire L Williams, Ilaria Marzinotto, Ben T Gillard, Elena Bazzigaluppi, Deborah Shoemark, Michela A-M Chandler, Peter Achenbach, Lorenzo Piemonti, Kathleen M Gillespie, Vito Lampasona, Alistair J K Williams, Josh Tyler, Anna E Long
Affiliations
- University of Bristol Medical School, Bristol, UK.
- IRCCS Ospedale San Raffaele, Milan, Italy.
- University of Bristol School of Biochemistry, Bristol, UK.
- Helmholtz Zentrum Munchen, Institute of Diabetes Research, Munich, Bavaria, Germany.
- Klinikum Rechts der Isar der Technischen Universitat Munchen, Munich, Bavaria, Germany.
- Jean Golding Institute, University of Bristol, Bristol, UK.
MeSH
Diabetes Mellitus, Luciferases, Autoantibodies, Insulin, Diabetes Mellitus, Type 1